ANNY SOSEBEE: Open Payments
NPI 1164916581 · DEMOREST, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 52 payments from 21 companies in 2025. Trend: 2023 $640 · 2024 $912 · 2025 $1,087
Food & beverage: $1,087
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 5 | $123 |
| Corcept Therapeutics | 5 | $112 |
| Vanda Pharmaceuticals Inc. | 5 | $109 |
| Xeris Pharmaceuticals, Inc. | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| ABBVIE INC. | 3 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Lilly USA, LLC | 3 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
Products named: BRIXADI, Korlym, FANAPT, GVOKE HYPOPEN, REXULTI, CAPLYTA, MOUNJARO, XIFAXAN.
Industry payments across GA — which companies pay providers there.
